Current Pharmacotherapies of Alcoholism: A U.S. Perspective
- 6 May 2003
- journal article
- review article
- Published by Wiley in The American Journal on Addictions
- Vol. 12 (s1), s53-s68
- https://doi.org/10.1111/j.1521-0391.2003.tb00496.x
Abstract
Advances in the neurobiology of addiction and improved clinical trial methodology have accelerated the evaluation of medication for alcoholism. While psychosocial interventions have been useful to reduce consumption and support abstinence, considerable improvement in treatment is needed. Medication can play a crucial role in the reduction of craving and drinking and the maintenance of abstinence. This article reviews pharmacotherapy for alcoholism with an emphasis on the perspective of the United States. The opiate antagonist naltrexone, the glutamate modulator acamprosate, and serotonergic agents will be highlighted in this review. In general, both naltrexone and acamprosate have been found in a number of studies to be efficacious agents for the treatment of alcohol dependence. Serotonin reuptake inhibitors have not consistently shown to be efficacious but may be useful in certain subgroups of alcoholics. The serotonin type‐3 antagonist, ondansetron, has shown promise in early‐onset alcoholics but needs more extensive study.Keywords
This publication has 74 references indexed in Scilit:
- Naltrexone in the Treatment of Alcohol DependenceThe New England Journal of Medicine, 2001
- Naltrexone and Cue Exposure With Coping and Communication Skills Training for Alcoholics: Treatment Process and 1‐Year OutcomesAlcohol: Clinical and Experimental Research, 2001
- Efficacy of Naltrexone and Acamprosate for Alcoholism Treatment: A Meta‐AnalysisAlcohol: Clinical and Experimental Research, 2001
- Update on Anticonvulsants for the Treatment of Alcohol WithdrawalThe American Journal on Addictions, 2001
- Drug Therapy for Alcohol DependenceThe New England Journal of Medicine, 1999
- Tolerability of Naltrexone in Treating Older, Alcohol‐Dependent PatientsThe American Journal on Addictions, 1997
- A Double‐Blind, Placebo‐Controlled Pilot Study to Evaluate the Efficacy and Safety of Oral Nalmefene HCI for Alcohol DependenceAlcohol: Clinical and Experimental Research, 1994
- Naltrexone and Brief Counseling to Reduce Heavy DrinkingThe American Journal on Addictions, 1994
- Implications of recent neuropsychopharmacologic research for understanding the etiology and development of alcoholism.Journal of Consulting and Clinical Psychology, 1994
- Alcohol‐induced reinforcement: Dopamine and 5‐HT3 receptor interactions in animals and humansDrug Development Research, 1993